Introduction
Ovarian cancer is the most lethal tumor of the female genital tract and continues to be the major cause of female cancer mortality (Hoskins, 1995; Wingo et al., 1995) . At present, a combination of paclitaxel with cisplatin is considered to be the best chemotherapy regimen for this aggressive cancer disease (Rowinsky et al., 1991; McGuire et al., 1995) . However, the overall 5-year survival rate following such treatment is still unsatisfactory (Ozols, 1995) . Thus, development of alternative therapeutic strategies is desirable in the management of this fatal disease.
Retinoids, the natural and synthetic derivatives of vitamin A, play an important role in regulating cellular growth and dierentiation (Sporn and Roberts, 1991; Lotan, 1980) . The inhibitory eect of retinoids on cancer has been known for many years. Retinoids have been demonstrated to inhibit development of a number of dierent types of epithelial tumors and to inhibit the growth of a variety of neoplastically transformed cells (De Luca, 1991; Lotan et al., 1990; Fontana, 1987; Koga and Sutherland, 1991) . A number of studies have determined that retinoids can inhibit the growth of human ovarian cancer. For example, treatment of a high risk population of women with the retinoid deviative fenretinide (4-HPR) resulted in a signi®cant reduction in the incidence of ovarian cancer (Formelli and Cleris, 1993) . Likewise, we and others have reported that all-trans retinoic acid (RA) is a very eective growth suppressor of the ovarian cancer cell line CA-OV3, but not the SK-OV3 cell line (Wu et al., 1997a (Wu et al., ,b, 1998 Soprano et al., 1996; Caliaro et al., 1994; Harant et al., 1993; Somay et al., 1991; Grunt et al., 1992) . The availability of RA sensitive and RA resistant cell lines provide a valuable resource for identi®cation of molecular components which are potentially responsible for RA inhibition of ovarian tumor cell growth.
The actions of retinoids are mediated by speci®c nuclear retinoid receptors that belong to the steroid/ thyroid hormone nuclear receptor superfamily (Evans, 1988; O'Malley, 1990) . Two distinct classes of nuclear proteins, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs) have been identi®ed (Gudas, 1992; Gudes et al., 1994; Lohnes et al., 1992) . Each class consists of a, b and g subtypes. RARs and RXRs form either homodimers or heterodimers and function as trans-acting nuclear transcriptional factors. They bind to their respective response elements-RAREs and RXREs in regulatory regions of target genes and modulate the expression of these genes in the presence of retinoids (Gudas, 1992; Leid et al., 1992) . It should be noted that heterodimers of RARs/RXRs bind much more ecently to RAREs than homodimers, thereby cooperating in RA-mediated gene regulation (Hermann et al., 1992; Zhang et al., 1992) . Since retinoids exert biological eects by acting through these two classes of nuclear receptors, it was logical to: (1) compare RAR and RXR expression and activity pro®les between CA-OV3 and SK-OV3 cell lines, (2) determine if these pro®les correlated to RA sensitivity and (3) determine if modulating the levels of these nuclear receptors altered the growth response of ovarian adenocarcinoma cells to RA.
Results

Comparison of the expression of RAR and RXR subtypes in CA-OV3 and SK-OV3 cells
We have previously shown that CA-OV3 cells are sensitive to growth inhibition by RA while SK-OV3 cells are resistant to the growth inhibitory activity of RA Wu et al., 1997a Wu et al., ,b, 1998 . To understand the molecular mechanism by which RA suppresses growth of ovarian tumor cells, we examined the levels of the nuclear receptors RAR (a, b, g) and RXR (a, b, g) in CA-OV3 cells and in SK-OV3 cells. CA-OV3 and SK-OV3 cells were treated with RA for 0, 3 or 6 h. Total RNA was isolated and Northern blots were prepared and probed with 32 P-labeled cDNAs speci®c for RAR-a, RXR-a, RAR-b, RXR-b, RAR-g and RXR-g. Figure 1a shows representative autoradiographs of the hybridizations. Hybridization signals were quantitated using a Fuji Phosphoimage Analyzer. After normalization to 28S mRNA levels, the relative level of each transcript was determined. These data are graphed in Figure 1b . RAR-b and RXR-g mRNAs were undetectable in both of these two cell lines. Level of RAR-g and RXR-b were not dierent in CA-OV3 compared to SK-OV3 cells and did not change upon treatment with RA. However, there were slightly higher levels of RAR-a (* 2-fold) and RXR-a (3*4-fold) in CA-OV3 cells compared to SK-OV3 cells. Furthermore, RA (10 76 M) treatment increased RAR-a mRNA levels in CA-OV3 cells but not in SK-OV3 cells.
DNA-binding and transcription transactivation activity of retinoid nuclear receptors is lower in SK-OV3 cells compared to CA-OV3 cells
We next compared the functional activity of RARs and RXRs in CA-OV3 and SK-OV3 cells. Initially, we employed the EMSA assay to analyse DNA binding activity. Nuclear extracts were isolated from CA-OV3 cells and SK-OV3 cells at 24 h after RA (10 76 M) treatment. The retinoic acid response element, DR-5, was used for this binding assay. Figure 2 shows the binding activity of retinoid nuclear receptors to the DR-5 element. It can be seen that the basal binding activity of nuclear extracts isolated from CA-OV3 cells was greater (*threefold) than from SK-OV3 cells. Furthermore, RA treatment signi®cantly enhanced this binding activity in CA-OV3 cells compared to that in SK-OV3 cells. Although RA treatment of SK-OV3 cells did increase DR-5 binding activity, this level was still less than that exhibited by CA-OV3 cells. RAR-RXR heterodimers are known to bind speci®cally to DR-5 RAREs (Mangelsdorf et al., 1994) . Thus the decreased DR-5 binding activity of SK-OV3 cell nuclear extracts is consistent with the lower levels of RAR-a and RXR-a mRNAs detected in RA-resistant SK-OV3 cells.
We next assayed the transcriptional transactivation activity of the endogenous retinoid nuclear receptors in CA-OV3 and SK-OV3 cells. RAR-b2 RARE-CAT was used as a reporter. This RARE is a natural DR-5 element found in the 5' regulatory region of the RAR-b2 gene. Figure 3 Eect of RA on the growth of SK-OV3 cells overexpressing RAR-a Since SK-OV3 cells are resistant to RA growth inhibition, and since these cells have lower levels of RAR-a mRNA than CA-OV3 cells when treated with RA, it was logical to investigate whether the sensitivity of SK-OV3 cells to RA inhibition could be modulated by overexpression of the RAR-a receptor. Because overexpression of RAR-a appeared to have a growthinhibitory eect, even in the absence of RA, it was necessary to use an inducible expression system for these experiments. We employed the Lac-switch vector system. SK-OV3 cells were co-transfected with the plasmids pOPRSVI-mRAR-a and p3'SS. Stable transfectants were selected by growth in medium supplemented with G418 and hygromycin B, resistant clones were isolated, expanded and charaterized for expression. We isolated 25 mRAR-a stable transfectant SK-OV3 cell clones. RNAse protection was used to detect the exogenous mouse RAR-a mRNA. The top panel of Figure 4a shows the induction of mRAR-a mRNA by IPTG in each of three representative clones. Higher levels of mRAR-a induction were obtained with clone a-15 and clone a-17, while a lower level of mRAR-a mRNA was detected in clone a-19. The bottom panel of Figure 4a shows that IPTG treatment of these clones induced synthesis of mRAR-a protein. Clone a-15 expressed the highest amount of mRAR-a protein, clone a-19, the least and clone a-17, an intermediate amount.
We employed the MTT assay to determine the growth response of these mRAR-a stable transfectant SK-OV3 clones to RA treatment. Figure 4b shows the results of this MTT assay. The SK-OV3 cells transfected with p3'SS and pOPRSVI empty vectors were used as controls (SK-M). It can be seen that in all of these clones, SK-OV3 became somewhat sensitive to RA growth inhibition (*20% inhibition) upon induction of mRAR-a by treatment with 1.5 mM IPTG. This result is due to induction of mRAR-a since we did not see any change of RA sensitivity following IPTG treatment of SK-OV3 cells transfected with the empty vectors (SK-M). These results suggest that modulation of the levels of RAR-a can aect the sensitivity of SK-OV3 cells to RA treatment. However, it should be noted that the level of RA sensitivity achieved by overexpression of RAR-a alone although statistically signi®cant, was only about 50% of that exhibited by the RA sensitive CA-OV3 cells (CA-M).
Eect of RA on the growth of SK-OV3 cells overexpressing mRXR-a
Since the expression of both RAR-a and RXR-a was found to be reduced in the RA resistant SK-OV3 cells, 76 M for 24 h. Nuclear extracts were isolated after treatment. Nuclear extracts from the cells treated with ethanol (7) were used as controls. Oligonucleotide fragments containing the DR-5 element were annealed and labeled with g 32 P-ATP as described in Materials and methods. FP: free DNA probe. Film was exposed overnight we next wished to determine whether overexpression of RXR-a could increase the RA sensitivity of SK-OV3 cells to a level comparable to that exhibited by the CA-OV3 cells. To answer this question, we transfected SK-OV3 cells with the plasmid pZeo-SV containing the full length RXR-a cDNA. SK-OV3 cells resistant to Zeocin were isolated, expanded and the presence and amount of mRXR-a mRNA assayed by RNAse protection. It should be noted that it was not necessary to employ an inducible expression system to overexpress RXR-a since consitutive expression of RXR-a did not alter cell growth. Figure 5a (top panel) shows that mRXR-a mRNA was constitutively over-expressed at dierent levels in three representative clones (clone X-1, X-3 and X-6). The lane labeled SK-M represents SK-OV3 cells transfected with empty pZeoSV vector as control. The bottom panel of Figure 5a shows that each of these clones also expressed increased amounts of mRXR-a protein as detected by Western blot analysis. Figure 5b shows the results of an MTT assay to determine the sensitivity of SK-OV3 cell clones constitutively overexpressing mRXR-a to RA growth suppression. It can be seen that SK-OV3 cells transfected with the empty vectors (SK-M) did not show any sensitivity to RA growth inhibition. However, each of the RXR-a overexpressing clones (X-1, X-3 and X-6) exhibited a dierence in sensitivity to growth inhibition by RA which was statistically signi®cant compared to the empty vector transfected control cell clone. Similar to what was observed upon overexpression of RAR-a, the maximum inhibition obtained (*25% for clone X-6) was only about 50% of that routinely exhibited by the RA-sensitive CA-OV3 cells.
Eect of RA on the growth of SK-OV3 cells overexpressing both mRAR-a and mRXR-a Since overexpression of RAR-a and RXR-a individually resulted in an increase in sensitivity of SK-OV3 cells to growth inhibition by RA, we next asked if this modest response could be enhanced by overexpression of both nuclear receptors. SK-OV3 clone a-15 was transfected with pZeoSV1-mRXR-a. Two representative clones, designated clones aX-1 and aX-5, were isolated, expanded, RAR-a and RXR-a overexpression con®rmed and the growth response to RA treatment determined. Figure 6a shows the results of the MTT assay. It can be seen that SK-OV3 cells transfected with the three empty vectors (SK-M) did not show any sensitivity to RA growth inhibition. The SK-OV3 clone a-15, which overexpresses only RAR-a, showed approximately 20% inhibition in response to RA treatment. This was consistent with the results shown in Figure 2b . Likewise, when the aX-1 and aX-5 clones, which overexpress both mRAR-a/RXR-a, were treated with RA in the absence of IPTG (i.e. conditions in which only the mRXR-a would be overexpressed) a 20 ± 30% inhibition of growth by RA treatment was observed (consistent with data presented in Figure 3b ). However, overexpression of both RAR-a and RXR-a was found to signi®cantly increase the sensitivity of the SK-OV3 cells to RA growth inhibition. Growth of clones aX-1 and aX-5 were inhibited by RA treatment to a level nearly comparable to that exhibited by the RA sensitive CA-OV3 cells transfected with all three empty vectors (CA-M).
These results were con®rmed by a second assay for cell growth, determination of DNA synthesis following [ 3 H]thymidine incorporation. Figure 6b shows that RA treatment of SK-OV3 cells overexpressing either mRAR-a (clone a-15) or mRXR-a (aX-1 and aX-5 in the abscence of IPTG) alone resulted in a 20 ± 30% reduction in the percentage of labeled nuclei compared to comparably treated empty vector control cells (SK-M). However, RA treatment of SK-OV3 cells overexpressing both mRAR-a and mRXR-a (aX-1 and aX-5 cells treated with IPTG) resulted in an even greater reduction of labeled nuclei following RA treatment (50 ± 55%). The results of these two growth assays clearly show that expression level of RAR-a and RXR-a is critical in determining the sensitivity of SK-OV3 cells to RA growth suppression. This was demonstrated by a third assay, growth in soft agar. Figure 7 shows representative photomicrographs of the soft agar assay. Figure 7a and b show that ®fteen days after RA treatment (10 76 M), few CA-OV3 cells formed colonies. In contrast, Figure 7c and d show that there was no apparent dierence in the size or number of colonies formed in the RA-treated and ethanol-treated SK-OV3 cells. However, significant reduction of colony formation was observed in SK-OV3 cells overexpressing RAR-a and RXR-a when these cells were treated with RA (Figure 7e and f). Figure 8 shows the results of a dose response experiment. It can be seen that various concentrations of RA (from 10 710 M to 10 76 M) had no eect on the formation of colonies in soft agar by the mocktransfected SK-OV3 cells. However, in SK-OV3 cells overexpressing mRAR-a/RXR-a, RA strongly suppressed the colony formation in a dose-dependent manner, similar to that of RA-sensitive CA-OV3 cells. It should be noted, however, that although the SK-aX cells were clearly sensitive to RA, they were not as sensitive as the CA-OV3 cells.
Functional redundancy between RAR family members in controlling sensitivity of SK-OV3 cells to RA growth inhibition A number of studies have shown that there is a considerable functional redundancy among members of the RAR family in the regulation of a number of target genes (Liu et al., 1996; Mendelsohn et al., 1994) . We wished to know whether there is also a functional redundancy in mediating RA-dependent growth inhibition of ovarian cancer cells. SK-OV3 cells were stably transfected with inducible mouse RAR-b2 or RAR-g1 and then cotransfected with mouse RXR-a as described previously. Induction of the expression of mouse RARb or RAR-g in stable transfectant clones was con®rmed by Western blot analysis (Figure 9a ). The MTT assay was then performed to determine the sensitivity of these stable transfectant clones to RA growth inhibition. Figure 9b shows that overexpression of either RAR-b or RAR-g alone made SK-OV3 cells become somewhat sensitive to RA growth inhibition. However, the extent of growth inhibition observed was not as signi®cant as that of SK-OV3 cells overexpressing RAR-a. This suggests that RAR-b or RAR-g can only partially substitute for the role of RAR-a in determining growth sensitivity to RA. Cooverexpression of either RAR-b or RAR-g with RXRa further increased the sensitivity of SK-OV3 cells to RA growth suppression, but levels of inhibition were not equal to SK-OV3 cells overexpressing RAR-a and RXR-a. 
Discussion
In the present study we have demonstrated: (1) the mRNA levels of RAR-a and RXR-a are *2 ± 3-fold lower in RA resistant SK-OV3 cells than those of RA sensitive CA-OV3 cells and the induction of RAR-a by RA is impaired in SK-OV3 cells; (2) RAR/RXR binding to consensus DR-5 RARE and transcriptional activation of a RAR-b2-RARE-CAT reporter was reduced in RA resistant SK-OV3 cells compared to RA sensitive CA-OV3 cells; (3) overexpression of RAR-a or RXR-a could partially convert SK-OV3 cells into RA sensitive cells; (4) coexpression of both RAR-a and RXR-a makes SK-OV3 cells nearly as sensitive to RA growth inhibition as CA-OV3 cells; and (5) overexpression of either RAR-b or RAR-g in combination with RXR-a made SK-OV3 cells become somewhat sensitive to RA growth inhibition. However, the extent of growth inhibition observed was not as signi®cant as that of SK-OV3 cells overexpressing RAR-a and RXR-a. These results provide strong evidence that RAR/RXR pro®le plays a critical role in determining the sensitivity of ovarian cancer cells to RA growth inhibition.
Our data are consistent with a number of recent studies done in the breast cancer cell model. In general, estrogen receptor positive breast cancer cell lines are sensitive to RA while estrogen receptor negative cells are resistant (Fontana, 1987; Koga and Sutherland, 1991; Zhao et al., 1995; Fontana et al., 1988; 1990; Lacroix and Lippman, 1980; Lotan, 1979; Marth et al., 1985 Marth et al., , 1993 Ueda et al., 1980; Wetherall and Taylor, 1986) . A number of reports have shown that RAR-a mRNA levels correlate with the sensitivity of breast cancer cell lines to growth inhibition by RA (van der Berg et al., 1993; Roman et al., 1992) . Moreover, Fontana and colleagues have shown that overexpression of RAR-a in the RA resistant estrogen receptornegative MDA-MB 231 cell line resulted in a signi®cant increase in sensitivity to RA growth inhibition . Likewise, this same group showed that overexpression of the estrogen receptor cDNA in estrogen receptor negative breast cancer cells led to an increase in RAR-a mRNA levels and a corresponding increase in sensitivity to growth inhibition by RA Roman et al., 1993) . Most recently, Dawson et al. (1995) , using a series of 14 conformationally restricted retinoid derivatives, showed that only those which exhibited high anity for RAR-a were able to mediate RA induced inhibition of breast tumor cell growth. In contrast, retinoids which speci®cally activated RXR homodimers were found to be ineective at inhibiting breast cancer cell growth. These ®ndings suggested that RAR/RXR heterodimers but not RAR/RAR or RXR/ RXR homodimers were important in mediating RA growth inhibition.
While the studies reported here in our ovarian cancer cell model are consistent with these reports, ours is the ®rst to directly examine the eect of overexpressing or activating both RAR-a and RXR-a. It is interesting to note that we found that overexpression of either RAR-a or RXR-a alone was only partly able to make SK-OV3 cells sensitive to RA inhibition. SK-OV3 cells overexpressing RAR-a or RXR-a alone were still not as sensitive to RA as CA-OV3 cells. Only when both RAR-a and RXR-a were overexpressed did the SK-OV3 cells become nearly as sensitive to RA inhibition as the CA-OV3 cells. These results are complemented by previous results from our laboratory showing the converse experiment in RA sensitive CA-OV3 cells. Antisense or dominant negative-mediated reduction in levels of either RAR-a or RXR-a in CA-OV3 cells was not sucient to make these cells resistant to RA. Only when levels of both receptors were reduced did CA-OV3 cells exhibit resistance to RA comparable to SK-OV3 cells (Wu et al., 1997b) . It should be noted, however, that our results in both studies suggest that there is no direct relationship between the absolute level of RAR and RXR and the sensitivity of the stable transfectant cells to growth suppression by RA. Surpringly, clones which overexpress high levels of RAR-a and RXR-a are not any more sensitive to RA growth inhibition than clones which express lower levels of these receptors. This suggests that a minimum threshold level of RAR and RXR is required to mediate growth suppression by RA. Once RAR and RXR levels exceed this threshold, RA-dependent growth regulatory functions are activated to the same extent regardless of the how much RAR and RXR are overexpressed.
Yet another line of evidence supporting the importance of both RAR and RXR in mediating ovarian tumor cell growth inhibition is provided by recent studies from our laboratory using receptor selective retinoids which show that maximum suppression of CA-OV3 cell growth requires treatment with both an RAR-selective and RXR-selective ligand (Wu et al., 1998) . Taken together, the ®ndings from these three studies provide strong evidence that heterodimers of RAR/RXR function better than homodimers of each individual receptor in mediating ovarian tumor cell growth inhibition by RA.
The molecular mechanism of RA growth inhibition of tumor cell lines is still unclear. It has been hypothesized that RA may aect the expression and/ or activation status of one or more growth-associated and/or tumor-suppressor genes. However, Sutherland and colleagues have shown that RA does not alter the expression or activity of a number of G-1 speci®c cyclins and cdks (Wilcken et al., 1996) It does, however, aect the phosphorylation status of the retinoblastoma protein (Wilcken et al., 1996) . Another possibility is that RA may cause tumor cells to dierentiate or undergo apoptosis as has been suggested by (Liu et al., 1996; Shao et al., 1995; Pellegrini et al., 1995) . However, in our previous studies we have been unable to obtain any molecular evidence suggesting that RA treated ovarian carcinoma cells undergo dierentiation or apoptosis (Wu et al., 1997a (Wu et al., ,b, 1998 . Moreover, we have observed that the RA block to cell cycle progression is reversible. This would suggest that RA is not inducing terminal dierentiation or programmed cell death in ovarian tumor cells. Yet a third possibility is that RA could inhibit the activity of the growth associated transcription factor AP-1 (van der Berg et al., 1995; Fanjul et al., 1994; Nagpal et al., 1995) . In fact, we have reported that AP-1 activity is inhibited by 50% upon RA treatment of CA-OV3 cells while there is no change in AP-1 activity in SK-OV3 cells by RA treatment . Moreover, transiently transfecting RAR-a, RAR-b or RAR-g plus RXR-a was able to signi®cantly suppress AP-1 activity in SK-OV3 cells to levels comparable to those observed following RA treatment of CA-OV3 cells . While de®nitive determination of the mechanism by which RA mediates growth inhibition awaits further study, our previous results suggest that inhibition of AP-1 activity may certainly be one of the molecular mechanisms by which RA suppresses growth of ovarian tumor cells.
Because retinoids are potent in vitro and in vivo growth inhibitors, and retinoid nuclear receptors are known to mediate their action, our present ®ndings suggest that RAR/RXR pro®les could be used to determine the potential therapeutic bene®t of RA or receptor-speci®c retinoid derivatives in treating ovarian cancer.
Materials and methods
Cell culture and reagents
The human ovarian adenocarcinoma cell lines SK-OV3 and CA-OV3 were obtained from the American Type Culture Collection (Rockville, MD). All stock cultures were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine and 100 units/ml penicillin and streptomycin and were maintained in a humidi®ed 5% CO 2 atmosphere at 378C. Cultures were passaged weekly at a ratio of 1:4 ± 1:8. Single cell clones of each cell line were prepared by the method of limiting dilution (Orth et al., 1994) . Despite the well known heterogeneous nature of these cell lines, our previous results showed that all single cell clones of SK-OV3 cells were resistant to the eects of all-trans retinoic acid (RA). In contrast, all single cell clones of CA-OV3 cells were growth inhibited by RA Wu et al., 1997a) . All studies reported in this paper used single cell clones SK-OV3-1 and CA-OV3-5.
All-trans RA was kindly provided by Homann LaRoche, Inc. (Nutley, NJ). 10 73 M stock solutions of RA were prepared in ethanol and stored at 7208C in an Eppendo tube wrapped with foil. All procedures involving RA were carried out under subdued light. Fresh RA stock was prepared every 2 weeks.
MTT (3,[4,5-dimethylthiazol-2-yl)2,5-dephenyl-tetrazolium bromide, thiazolyl blue) was purchased from Sigma. MTT was dissolved in sterile phosphate buer solution (PBS) at room temperature and further sterilized by ®ltration. The 5 mg/ml stock solution was stored at 48C in a dark bottle equipped with a tight cap. The MTT solution was prepared fresh every month.
Geneticin (G418) was purchased from Life Technologies, Hygromycin B was obtained from Sigma. Both were dissolved in 100 mM HEPES (pH 7.3), and sterilized by ®ltration. Zeocin (100 mg/ml) was purchased from Invitrogen. Isopropyl-b-D-thiogalactoside (IPTG) was obtained from Strategene and dissolved in PBS at the concentration of 1.0 M and sterilized by ®ltration, stored at 7208C in dark.
Plasmid constructs
A 2.1 kb mouse RAR-a1 cDNA containing the entire coding sequence was removed from pSG5-mRAR-a1 by EcoRI digestion, adaptors containing the NotI restriction site annealed onto both ends and then subcloned into the NotI site of the Lac Switch TM Inducible Mammalian Expression System (Stratagene) pOPRSVI vector. The plasmid containing the mRAR-a in the sense orientation was called pOPRSVI-mRAR-a1. The 1.3 kb mouse mRAR-b2 coding sequence was ampli®ed by PCR from pSG5-mRAR-b and was cloned in the sense orientation into the NotI site of pOPRSVI and named pOPRSVI-mRAR-b2. The 1.3 kb mouse mRAR-g1 coding region was ampli®ed by PCR from pSG5-mRAR-g and was inserted into pOPRSVI/NotI site in the sense orientation and named pOPRSVI-mRAR-g1. A 1.8 kb fragment of the mouse RXR-a cDNA containing the entire coding sequence was obtained from pSG5-mRXRa by EcoRI digestion, and subcloned into the mammalian expression vector, pZeoSV (Invitrogen). The plasmid containing the mRXR-a in the sense orientation was called pZeoSVmRXR-a.
The integrity of all PCR generated clones was con®rmed by DNA sequence analysis.
Stable transfections
To prepare stable transfectants containing inducible expression vectors of sense mRAR-a, mRAR-b-or mRAR-g, ovarian cancer cells were initially plated at a density of 1.0610 6 cells/100-mm dish 24 h prior to transfection. Ten mg of the appropriate inducible expression plasmid and 15 mg of plasmid p3'SS were cotransfected using the calcium phosphate-DNA coprecipitation method (Promega Corp.). Control cells were transfected with the same amount of p3'SS and the empty plasmid pOPRSVI. Forty-eight hours after transfection, the cells were switched to the selective medium (containing 800 mg/ ml of G418 and 400 mg/ml of hygromycin B) and refed with the same selective medium every 3 days. Three weeks later, cell clones, which were resistant to both G418 and hygromycin B, were isolated and expanded. The inducible stable transfectant clones were subsequently analysed by RNAse protection assay and Western blot analysis.
To obtain clones constitutively expressing mRXR-a, ovarian cancer cells were transfected with 10 mg of pZeoSVmRXR-a. Cells transfected with empty pZeoSV vector were prepared as controls. Forty-eight hours after transfection, the transfected cells were fed with the selective medium containing 200 mg/ml of Zeocin. In those cases in which it was desirable to obtain clones in which both RAR and RXR were overexpressed in the same cells, a selective medium containing 200 mg/ml of Zeocin, 800 mg/ml of G418 and 400 mg/ml of hygromycin B was used. Cell clones which were resistant to all three antibiotics were isolated 3 weeks after transfection. Control cells were transfected with p3'SS and the two empty vectors pZeoSV and pOPRSVI. Expression of both the appropriate mRAR and mRXR-a RNAs and proteins was con®rmed by RNAse protection assay and Western blot analysis.
Determination of cell growth
Growth was analysed by three assays: the MTT assay, determination of DNA synthesis by autoradiography and anchorage independent growth in soft agar. The MTT assay is based on the cellular dependent reduction of MTT by mitochondrial dehydrogenase (found only in viable cells) to a blue formazan product which can be measured spectrophotometrically (Carmichael et al. 1987) . Based on the modi®ed method of Berg et al. (1990) , cells were plated in 96-well¯at bottom tissue culture dishes at a density of 5000 cells/well in the selective medium described above. Two days later, the cells were treated with 1.5 mM IPTG plus ethanol or 1.5 mM IPTG plus 10 76 M RA. The medium was changed every 2 days to maintain the concentration of IPTG and RA. We have tested dierent doses of IPTG. A concentration of 1.5 mM showed the optimal induction capacity with no eect on the growth of ovarian cancer cells. The control group was treated with PBS and ethanol. Seven days after treatment, the medium was completely removed from all wells, 125 ml (containing 100 ml of the regular medium and 25 ml of 5 mg/ml of MTT) medium was added to each well. Following a 3 h incubation in a CO 2 incubator at 378C, 100 ml extraction buer (20% w/v of SDS is dissolved in a solution of 50% of each N, N-dimethyl folmamide (DMF) and demineralized water, pH adjusted to 4.7 by addition of 2.5% of an 80% acetic acid and 2.5% 1 N HCl solution) was added to each well. After the plates were incubated at 378C overnight, the absorbance at 590 nm (I T ) was measured using an ELISA reader (I R =660 nm). All cell growth experiments were performed in quadruplicate and repeated at least three independent times. The mean values+standard deviation are reported.
For determination of DNA synthesis, cells growing on glass cover slips in 60-mm dishes were treated with RA and/ or IPTG at the same concentration and time course as above. On day 7 after treatment, 0.5 mCi/ml [ 3 H]-thymidine was added to each dish, 6 h later, the cover slips were harvested, ®xed in absolute methanol and processed for autoradiography as described previously (Owen et al., 1989; Zhao et al., 1995) . All labeling indexes represent the % labeled nuclei after counting a minimum of 500 cells and were performed in triplicate and are expressed as the mean+standard deviation.
Anchorage-independent growth was determined by using a growth in soft agar assay as described by Lotan et al. (1990) . Brie¯y, 1610 5 cells were suspended in complete medium containing 0.3% agar, 1.5 mM IPTG and various concentrations of either all-trans-RA or ethanol. This suspension was added to 60 mm tissue culture dishes containing a solidi®ed base agar consisting of complete culture medium supplemented with 0.6% agar. After 15 days, each plate was examined microscopically and the number of foci containing 25 or more cells was determined in at least ®ve ®elds under 1006magni®cation.
RNA isolation
Total cellular RNA was isolated by the RNAzol method (Rappolee et al., 1989 ) (Cinna/Biotecx Laboratories). RNA was quantitated by absorbance at 260 nm, and purity was assessed by absorbance at 280 nm. Integrity of each RNA sample was con®rmed by analysis on agarose-formaldehyde gels stained with ethidium bromide as described previously Cosenza et al., 1988) .
Detection of steady state mRNA levels
The steady state levels of RAR (a, b, g) and RXR (a, b, g) in SK-OV3 and CA-OV3 cell lines were determined by Northern blot (Thomas, 1988) . Brie¯y, 30 mg of total RNA of each sample was displayed on a 1% agaroseformaldehyde gel, then transfered to nitrocellulose. Prehybridization, hybridization, and washing conditions were performed as described by Soprano et al. (1987) . Intensity of hybridization signals were quantitated using a Fuji Phosphoimager. A 2.1 kb EcoRI fragment from pSG5-mRAR-a, a 1.8 kb EcoRI fragment from pSG5-mRARb and a 1.8 kb EcoRI fragment from pSG5-mRARg were used to detect RAR-a, RAR-b and RAR-g mRNA levels, respectively. A 776 bp BamHI fragment from pSKRXR3-1 containing about half of the coding region from the 5' end of the cDNA was puri®ed and used as a probe for RXR-a A 1.3 kb EcoRI ± HindIII fragment from pTL-1 was used as a probe for RXR-b and a 1.4 kb EcoRI fragment from pSG5-mRXR-g was puri®ed and used as a probe for RXR-g. A normalizing probe, 28S rRNA, was used to con®rm that equal amounts of RNA from each sample were loaded. All puri®ed fragments were labeled with a 32 P-dCTP by random priming using the Prime-aGene Labeling System (Promega Corp.).
The RNAse protection assay was used to con®rm speci®c overexpression of exogenously transfected mouse RARs and/ or RXR-a in the stable transfectant cell clones. The method as described by Toscani et al. (1987) was used. Anti-sense RNA probes for mRARs and mRXR-a were synthesized as described in Harnish et al., (1992) .
Western blot analysis
The Western blot procedure was used to con®rm overexpression of RARs and RXR-a in stable transfactants. Nuclear extracts were analysed as described by Soprano et al. (1994) . Monoclonal antibody to RAR-a was purchased from Anity Bioreagents. Monoclonal antibody to RXR-a was obtained from Santa Cruz Biotechnology. Thè Enhanced Chemiluminescence' (ECL) kit (Amersham) was used to detect the reaction signals.
Electromobility Shift Assay (EMSA)
Nuclear extracts were isolated as described by Wu et al. (1996) and stored at 7708C. Protein concentration was determined by the method of Bradford (1976) (BioRad) . The gel retardation assay was performed as described previously (Carter et al., 1991; PenÄ a et al., 1993) using as DR-5 probe containing the consensus RAR-b2 RARE endlabeled with 32 P g-ATP by T4 polynucleotide kinase. Five mg of nuclear extract was used for each assay.
CAT assays
To determine RAR/RXR transcriptional transactivation activity, CA-OV3 and SK-OV3 cells were grown in DMEM containing 10% FBS and plated in 60-mm tissue culture dishes at a concentration of 5610 6 cells/dish. Twenty-four hours later, they were transfected by the calcium phosphate precipitation method with a total of 7 mg of total DNA including 5 mg of pRAR-b2-RARE-CAT and 2 mg of pRSV-b-gal. The precipitates were removed 24 h after transfection, and the cells were refed with fresh medium containing either ethanol or RA. Forty-eight hours after transfection, the cells were harvested, and the cell lysates were prepared and assayed for b-galactosidase (Eustice et al., 1991) and CAT activity (Seed and Sheen, 1988) . CAT values were then corrected for transfection eciency using the b-galactosidase activity. All CAT assay experiments were repeated at least three independent times, and the averaged values+standard deviation are reported.
Statistical analysis
All cell growth experiments were performed in tetraplicate and repeated at least three independent times. The mean values+standard deviation are reported. Group comparison was made by student t-test. Dierences having a P value 50.05 or 50.01 are reported as statistically signi®cant and are designated with the symbol (*) or (**) respectively.
